We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EB
2301
DELISTED
Eventbrite
EB
| $2.22M | ﹤0.01% |
258,697
+108,762
| +73% | +$960K |
|
|
PAE
2302
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $2.21M | ﹤0.01% |
+231,551
| New | +$2.06M |
|
|
NGM
2303
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $2.21M | ﹤0.01% |
112,118
-2,320
| -2% | -$44.3K |
|
2304
Tucows
TCX
$175M
| $2.21M | ﹤0.01% |
38,571
+1,614
| +4% | +$89.6K |
|
2305
China Yuchai International
CYD
$1.78B
| $2.21M | ﹤0.01% |
153,728
+14,228
| +10% | +$177K |
|
2306
Ecovyst
ECVT
$1.14B
| $2.21M | ﹤0.01% |
166,819
+11,540
| +7% | +$136K |
|
|
WTRE
2307
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $2.21M | ﹤0.01% |
+132,314
| New | +$1.9M |
|
2308
CVR Energy
CVI
$3.13B
| $2.21M | ﹤0.01% |
109,666
-1,972
| -2% | -$39.8K |
|
|
ATHX
2309
DELISTED
Athersys, Inc. Common Stock
ATHX
| $2.21M | ﹤0.01% |
31,956
+5,537
| +21% | +$385K |
|
|
PR
2310
Permian Resources
PR
$16.9B
| $2.19M | ﹤0.01% |
2,463,361
+1,790,874
| +266% | +$1.58M |
|
|
ACBI
2311
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $2.19M | ﹤0.01% |
179,863
-47,926
| -21% | -$550K |
|
|
EBIX
2312
DELISTED
Ebix Inc
EBIX
| $2.18M | ﹤0.01% |
97,461
+6,197
| +7% | +$128K |
|
|
SYRS
2313
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.17M | ﹤0.01% |
20,329
+6,466
| +47% | +$580K |
|
2314
Banc of California
BANC
$2.97B
| $2.16M | ﹤0.01% |
199,667
-2,719
| -1% | -$27.3K |
|
2315
First Financial Corp
THFF
$969M
| $2.16M | ﹤0.01% |
58,655
-3,207
| -5% | -$109K |
|
|
TBI
2316
Trueblue
TBI
$311M
| $2.16M | ﹤0.01% |
141,334
+1,403
| +1% | +$20.8K |
|
|
QADA
2317
DELISTED
QAD Inc.
QADA
| $2.14M | ﹤0.01% |
51,860
+761
| +1% | +$32.1K |
|
|
SWI
2318
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.13M | ﹤0.01% |
114,510
-36,100
| -24% | -$666K |
|
2319
Triumph Financial Inc
TFIN
$1.82B
| $2.13M | ﹤0.01% |
87,716
-10,638
| -11% | -$261K |
|
|
TBRG
2320
DELISTED
TruBridge
TBRG
| $2.13M | ﹤0.01% |
93,260
-40,016
| -30% | -$893K |
|
2321
Buckle
BKE
$2.37B
| $2.11M | ﹤0.01% |
134,577
+22,775
| +20% | +$341K |
|
|
LGTY
2322
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $2.11M | ﹤0.01% |
133,841
-43,255
| -24% | -$727K |
|
2323
Caesarstone
CSTE
$79.5M
| $2.11M | ﹤0.01% |
177,731
+19,435
| +12% | +$205K |
|
|
APLT
2324
DELISTED
Applied Therapeutics
APLT
| $2.1M | ﹤0.01% |
57,965
+20,815
| +56% | +$871K |
|
|
AD
2325
Array Digital Infrastructure
AD
$3.05B
| $2.07M | ﹤0.01% |
67,177
-295
| -0.4% | -$9.09K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.